Institutional investors hold a majority ownership of MRK through the 76.30% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2016, these large investors purchased a net $24.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TCW INVESTMENT MANAGEMENT CO. Bought 241.1 Thousand shares of Merck
CIBC WORLD MARKETS, INC. Bought 187.1 Thousand shares of Merck